worldwide offices | contact | help | sitemap

 

 

 

 

About Novartis Vaccines

About Novartis Vaccines

Investors

Novartis (NYSE: NVS), which was created in 1996 by the merger of the Swiss companies Ciba-Geigy and Sandoz, is a world leader in the research and development of products that protect and improve health and well-being. Its core businesses are in pharmaceuticals, vaccines, consumer health, generics, eye care, and animal health.

 

Disease & products

disease & products

Learn about meningitis, influenza, rabies, TBE and japanese encephalities.

NYSE

SWX

 
 

NVS

 
 

NOVZn